Glaxo ponders hostile bid for SmithKline

In a last-ditch attempt to salvage the largest corporate deal in history, Glaxo Wellcome is considering launching a no-premium hostile takeover bid for SmithKline Beecham after friendly merger talks between the two drugs giants broke down.

If the ambitious and ground-breaking deal were to go ahead, Glaxo would assume control of its rival and orchestrate a purge of SmithKline's management, including the removal of Jan Leschly, its chief executive.

The innovative deal, designed to appease Glaxo's disgruntled shareholders, would mark the latest twist in the battle for control of what would be the biggest drugs company in the world.

Glaxo is exploring the possibility of putting forward the same terms of the original merger to the City, whereby its shareholders would take a 59.5 per cent stake in the combined group. The idea would be to offer shareholders the chance to realise the huge potential value the original deal would have created, which appeared to be lost once talks between the two sides broke down after a bitter dispute between Jan Leschly and Sir Richard Sykes, Glaxo's chairman.

The group is understood to be planning to test the water by discussing the idea with some of its largest institutional shareholders in an effort to recruit their support for such a deal.

Several large shareholders indicated yesterday they would consider it, in an effort to reap potential merger benefits.

Glaxo is understood to have ruled out launching a hostile bid at a significant premium to SmithKline's current share price. Any such deal would threaten to wipe out the potential cost savings from a merger and have the effect of transferring value to SmithKline's shareholders.

Glaxo and SmithKline stunned and angered the City earlier this week by announcing that merger talks had fallen through, an embarrassing episode which wiped pounds 13bn off the value of the two groups. The merger was the biggest deal in corporate history and would have created the largest drugs group in the world.

The original deal foundered after an acrimonious clash between senior executives. Glaxo is believed to have become increasingly concerned that Mr Leschly and Jean Pierre Garnier, SmithKline's operations director, were seeking to dominate the company.

SmithKline is run in a centralised way with Mr Leschly keeping a firm grip on all the group's divisions. That sat uneasily with Glaxo's devolved structure. Although Richard Sykes retains a tight rein on the business, much more responsibility is divested to divisional managers.

Glaxo was worried that Mr Leschly would have sought to run large swathes of the combined pharmaceuticals group from his American base in Philadelphia.Analysts estimate that a merger would bring costs savings of up to pounds 1.5bn a year. A combined group would also create a research and development powerhouse with annual expenditure of a least pounds 2bn. City observers were also excited about the combination of Glaxo's and SmithKline's long-term drug development programmes which could have produced a lucrative pipeline of new treatments.

Glaxo's shares rose 19p to 1757p yesterday, well short of 1985p, the price the stock achieved when merger talks were first announced. SmithKline's shares slipped 18p to 748p yesterday.

Start your day with The Independent, sign up for daily news emails
ebooksAn introduction to the ground rules of British democracy
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

SThree: Talent Acquisition Consultant

£22500 - £27000 per annum + OTE £45K: SThree: Since our inception in 1986, STh...

Recruitment Genius: Experienced Financial Advisers and Paraplanners

Negotiable: Recruitment Genius: This extremely successful and well-established...

Guru Careers: FX Trader / Risk Manager

Competitive with monthly bonus: Guru Careers: We are seeking an experienced FX...

Guru Careers: Investment Writer / Stock Picker

Competitive (Freelance) : Guru Careers: An Investment Writer / Stock Picker is...

Day In a Page

How to stop an asteroid hitting Earth: Would people co-operate to face down a global peril?

How to stop an asteroid hitting Earth

Would people cooperate to face a global peril?
Just one day to find €1.6bn: Greece edges nearer euro exit

One day to find €1.6bn

Greece is edging inexorably towards an exit from the euro
New 'Iron Man' augmented reality technology could help surgeons and firefighters, say scientists

'Iron Man' augmented reality technology could become reality

Holographic projections would provide extra information on objects in a person's visual field in real time
Sugary drinks 'are killing 184,000 adults around the world every year'

Sugary drinks are killing 184,000 adults around the world every year

The drinks that should be eliminated from people's diets
Pride of Place: Historians map out untold LGBT histories of locations throughout UK

Historians map out untold LGBT histories

Public are being asked to help improve the map
Lionel, Patti, Burt and The Who rock Glasto

Lionel, Patti, Burt and The Who rock Glasto

This was the year of 24-carat Golden Oldies
Paris Fashion Week

Paris Fashion Week

Thom Browne's scarecrows offer a rare beacon in commercial offerings
A year of the caliphate:

Isis, a year of the caliphate

Who can defeat the so-called 'Islamic State' – and how?
Marks and Spencer: Can a new team of designers put the spark back into the high-street brand?

Marks and Spencer

Can a new team of designers put the spark back into the high-street brand?
'We haven't invaded France': Italy's Prime Minister 'reclaims' Europe's highest peak

'We haven't invaded France'

Italy's Prime Minister 'reclaims' Europe's highest peak
Isis in Kobani: Why we ignore the worst of the massacres

Why do we ignore the worst of the massacres?

The West’s determination not to offend its Sunni allies helps Isis and puts us all at risk, says Patrick Cockburn
7/7 bombings 10 years on: Four emergency workers who saved lives recall the shocking day that 52 people were killed

Remembering 7/7 ten years on

Four emergency workers recall their memories of that day – and reveal how it's affected them ever since
Humans: Are the scientists developing robots in danger of replicating the hit Channel 4 drama?

They’re here to help

We want robots to do our drudge work, and to look enough like us for comfort. But are the scientists developing artificial intelligence in danger of replicating the TV drama Humans?
Time to lay these myths about the Deep South to rest

Time to lay these myths about the Deep South to rest

'Heritage' is a loaded word in the Dixie, but the Charleston killings show how dangerous it is to cling to a deadly past, says Rupert Cornwell
What exactly does 'one' mean? Court of Appeal passes judgement on thorny mathematical issue

What exactly does 'one' mean?

Court of Appeal passes judgement on thorny mathematical issue